Clinical Trial Update: Role of Anti-IgE in Severe Childhood Eczema [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating anti-IgE therapy for severe childhood eczema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Atopic Eczema
• Child

Snippet

Sponsor: Guy's and St Thomas' NHS Foundation Trust | Conditions: Atopic Eczema, Atopic Dermatitis | Phase 4 | Status: COMPLETED